Cassin M, Charmet P A, Rellini G, Molaro G, Bitto S, Brieda M, Zanuttini D
Ospedale S. Maria degli Angeli, Pordenone.
G Ital Cardiol. 1987 Jul;17(7):601-4.
The purpose of this study is to analyze the relationship between occurrence of hemorrhagic complications, kinetic of fibrinogen degradation-regeneration and the changes of prothrombin time (PT), partial thromboplastin time (PTT), after intravenous administration of Streptokinase (SK), 1.500.000 U., in acute myocardial infarction. 45 selected patients with acute myocardial infarction had pretreatment analysis and serial post-SK measurement of fibrinogen levels, PT, PTT (for 48 hours). Basal fibrinogen levels were 3.2 g/l and displayed significant depression for 18 hours (0.30-0.46 g/l) and normalization after 30 hours from SK infusion. Similar behaviour showed PT and PTT. Minor bleeding was identified in 25 patients. In bleeders mean fibrinogen levels, PT, PTT before and maximum changes after SK were not significantly different compared with non bleeders. We conclude that SK infusion produces important and prolonged changes of fibrinogen levels, PT, PTT; hemorrhagic risk is not related, however, to the extent of lytic state, but probably to pre-existent vascular derangement, predisposing to bleeding complications during fibrinolytic therapy. Therefore we believe to be prudent to delay the infusion of heparin for 12-18 hours after SK administration, when fibrinogen levels are beginning to increase.
本研究的目的是分析急性心肌梗死患者静脉注射150万单位链激酶(SK)后出血并发症的发生、纤维蛋白原降解 - 再生动力学以及凝血酶原时间(PT)、部分凝血活酶时间(PTT)的变化之间的关系。45例入选的急性心肌梗死患者在SK治疗前进行了分析,并在SK治疗后连续48小时测量纤维蛋白原水平、PT、PTT。基础纤维蛋白原水平为3.2 g/l,在18小时内显著降低(0.30 - 0.46 g/l),SK输注后30小时恢复正常。PT和PTT表现出类似的变化。25例患者出现轻微出血。出血患者与未出血患者相比,SK治疗前的平均纤维蛋白原水平、PT、PTT以及SK治疗后的最大变化无显著差异。我们得出结论,SK输注会导致纤维蛋白原水平、PT、PTT发生重要且持久的变化;然而,出血风险与纤溶状态的程度无关,可能与先前存在的血管紊乱有关,这使得在纤维蛋白溶解治疗期间易发生出血并发症。因此,我们认为在SK给药后12 - 18小时,当纤维蛋白原水平开始升高时,推迟肝素输注是谨慎的做法。